EP1817444A4 - Squelettes proteiques et leurs utilisations - Google Patents

Squelettes proteiques et leurs utilisations

Info

Publication number
EP1817444A4
EP1817444A4 EP05857979A EP05857979A EP1817444A4 EP 1817444 A4 EP1817444 A4 EP 1817444A4 EP 05857979 A EP05857979 A EP 05857979A EP 05857979 A EP05857979 A EP 05857979A EP 1817444 A4 EP1817444 A4 EP 1817444A4
Authority
EP
European Patent Office
Prior art keywords
protein scaffolds
uses therof
therof
scaffolds
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP05857979A
Other languages
German (de)
English (en)
Other versions
EP1817444A2 (fr
Inventor
Willem P C Stemmer
Martin Vogt
Joost A Kolkman
Josh Silverman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Mountain View Inc
Original Assignee
Avidia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avidia Inc filed Critical Avidia Inc
Publication of EP1817444A2 publication Critical patent/EP1817444A2/fr
Publication of EP1817444A4 publication Critical patent/EP1817444A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP05857979A 2004-11-16 2005-11-16 Squelettes proteiques et leurs utilisations Ceased EP1817444A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62859604P 2004-11-16 2004-11-16
PCT/US2005/041639 WO2006127040A2 (fr) 2004-11-16 2005-11-16 Squelettes proteiques et leurs utilisations

Publications (2)

Publication Number Publication Date
EP1817444A2 EP1817444A2 (fr) 2007-08-15
EP1817444A4 true EP1817444A4 (fr) 2010-02-17

Family

ID=37452497

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05857979A Ceased EP1817444A4 (fr) 2004-11-16 2005-11-16 Squelettes proteiques et leurs utilisations

Country Status (6)

Country Link
EP (1) EP1817444A4 (fr)
JP (1) JP2008520208A (fr)
AU (1) AU2005332022A1 (fr)
CA (1) CA2587463A1 (fr)
MX (1) MX2007005865A (fr)
WO (1) WO2006127040A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005673A1 (en) 2001-06-29 2004-01-08 Kevin Jarrell System for manipulating nucleic acids
US7435562B2 (en) 2000-07-21 2008-10-14 Modular Genetics, Inc. Modular vector systems
EP1817413B1 (fr) 2004-11-11 2012-01-04 Modular Genetics, Inc. Ensemble et système d'échelle d'oligonucléotide pour produire de la diversité moléculaire
MX347295B (es) 2009-03-20 2017-04-20 Amgen Inc Inmunoglobulinas portadoras y usos de las mismas.
WO2012040518A2 (fr) 2010-09-22 2012-03-29 Amgen Inc. Immunoglobulines porteuses et leur utilisation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018995A2 (fr) * 2002-08-23 2004-03-04 Williams Kevin J Fragments de thrombospondine et utilisations dans des essais cliniques sur le cancer et production d'anticorps et autres agents de liaison
WO2004044011A2 (fr) * 2002-11-06 2004-05-27 Avidia Research Institute Bibliotheques combinatoires de domaines de monomere

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002256371B2 (en) * 2001-04-26 2008-01-10 Amgen Mountain View Inc. Combinatorial libraries of monomer domains

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018995A2 (fr) * 2002-08-23 2004-03-04 Williams Kevin J Fragments de thrombospondine et utilisations dans des essais cliniques sur le cancer et production d'anticorps et autres agents de liaison
WO2004044011A2 (fr) * 2002-11-06 2004-05-27 Avidia Research Institute Bibliotheques combinatoires de domaines de monomere

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LAWLER J ET AL: "THE STRUCTURE OF HUMAN THROMBOSPONDIN, AN ADHESIVE GLYCOPROTEIN WITH MULTIPLE CALCIUM-BINDING SITES AND HOMOLOGIES WITH SEVERAL DIFFERENT PROTEINS", THE JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, US, vol. 103, 1 November 1986 (1986-11-01), pages 1635 - 1648, XP002932599, ISSN: 0021-9525 *

Also Published As

Publication number Publication date
MX2007005865A (es) 2008-02-25
WO2006127040A3 (fr) 2009-04-09
EP1817444A2 (fr) 2007-08-15
JP2008520208A (ja) 2008-06-19
WO2006127040A2 (fr) 2006-11-30
CA2587463A1 (fr) 2006-11-30
AU2005332022A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
EP1824796A4 (fr) Squelettes proteiques et leurs utilisations
EP1802588A4 (fr) Amino-pyrimidones substitues et utilisation de ceux-ci
HK1214812A1 (zh) 新的羥基- -雜芳基菲啶及其作爲 抑制劑的用途
IL179300A0 (en) Novel-antigen-binding polypeptides and their uses
IL181670A0 (en) Substituted phenylaminothiazoles and use thereof
IL176692A0 (en) Membrane scaffold proteins
IL218487A0 (en) Processes and intermediates
IL179497A0 (en) Carboranylporphyrins and uses thereof
EP1799840A4 (fr) Polypeptides ilt3 et utilisations
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
EP1737565A4 (fr) Configurations et procedes claus pour cos
IL184062A0 (en) Visco-supplement composition and methods
IL180365A0 (en) Carboranylporphyrins and uses thereof
EP1817444A4 (fr) Squelettes proteiques et leurs utilisations
EP1786415A4 (fr) Agents de modulation du métabolisme et utilisations associées
HRP20140660T1 (en) Compositions and uses therof
IL177759A0 (en) Cospeptin, cosmedin and their uses
EP1813671A4 (fr) Protéine soluble et utilisation de celle-ci
EP1810976A4 (fr) Dérivé de benzonaphthacèneglycoside et utilisation dudit dérivé
GB0424552D0 (en) Methods and means
GB0403847D0 (en) Methods and means
ZA200706038B (en) Visco-supplement composition and methods
EP1735334A4 (fr) Proteines set1 et utilisations associees
GB0421911D0 (en) Methods and means
GB0425893D0 (en) Scaffold fitting

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070615

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20090409

RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 21/06 20060101ALI20090929BHEP

Ipc: C07K 1/00 20060101AFI20090929BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100115

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101ALI20100111BHEP

Ipc: C12P 21/06 20060101ALI20100111BHEP

Ipc: C07K 1/00 20060101AFI20090929BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20101113